Glioma
📧 Sign up to get email alerts when something new happens for Glioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-07-02Clinical Trial Update: Image-Based Quantitative Assessment of Acute Radiation-Induced Changes in Glioma [NA]
Clinical trial update on image-based quantitative assessment of acute radiation-induced changes in glioma; study terminated with results pos…
-
CLINICAL_TRIALS trial_result · 2019-05-29Clinical Trial Update: Safety Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Tumors of the Brain [Phase 2]
Phase 2 safety study of Aminolevulinic Acid (ALA) to enhance visualization and resection of brain tumors (glioma) has been terminated with r…
-
CLINICAL_TRIALS trial_result · 2019-02-28Clinical Trial Update: Bevacizumab in Recurrent Grade II and III Glioma [Phase 2]
Phase 2 clinical trial update evaluating bevacizumab for recurrent grade II and III glioma has been completed.
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma [Phase 1, Phase 2]
A Phase 1/2 study of intraventricular liposomal cytarabine (DepoCyt) for recurrent glioblastoma was terminated, and results have been posted…
-
CLINICAL_TRIALS trial_result · 2019-02-06Clinical Trial Update: Repeat Radiation, Minocycline and Bevacizumab in Patients With Recurrent Glioma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating repeat radiation, minocycline, and bevacizumab in patients with recurrent glioma has completed with resu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-10-31Clinical Trial Update: Phase I Trial of Intramural Injection of DTI-015 for Recurrent Malignant Gliomas [Phase 1, Phase 2]
Phase I/II trial of intramural DTI-015 for recurrent malignant gliomas has been completed.
-
CLINICAL_TRIALS trial_result · 2018-10-12Clinical Trial Update: Safety of BBB Opening With the SonoCloud [Phase 1, Phase 2]
Phase 1/2 trial update on safety of SonoCloud-induced BBB opening for glioblastoma and glioma patients; study completed.
-
CLINICAL_TRIALS trial_result · 2018-09-28Clinical Trial Update: PVSRIPO for Recurrent Glioblastoma (GBM) [Phase 1]
Phase 1 clinical trial update for PVSRIPO in recurrent glioblastoma (GBM) completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: GW572016 to Treat Recurrent Malignant Brain Tumors [Phase 2]
Phase 2 trial of GW572016 (lapatinib) for recurrent malignant brain tumors has completed.
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Study of Crenolanib, a Selective and Potent Inhibitor of PDGFR, for the Treatment of Adult Gliomas [Phase 2]
A Phase 2 trial of crenolanib for adult gliomas has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-grade Glioma [Phase 1]
This is a terminated Phase 1 open-label study evaluating convection-enhanced delivery of IL-13-PE38QQR in pediatric diffuse infiltrating bra…
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma [Phase 1, Phase 2]
Phase 1/2 clinical trial assessing plerixafor after radiation therapy and temozolomide in newly diagnosed high-grade glioma has completed wi…
-
CLINICAL_TRIALS trial_result · 2018-06-28Clinical Trial Update: Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas
A completed clinical trial update examining factors associated with the development of blood clots in patients undergoing treatment for newl…
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy [Phase 1, Phase 2]
Clinical trial update for SU5416 (Semaxanib) in patients with recurrent astrocytoma or mixed glioma after radiation failure; the Phase 1/2 s…
-
CLINICAL_TRIALS trial_result · 2018-06-26Clinical Trial Update: Emend and Ondansetron Compared to Ondansetron Alone to Prevent CINV in Glioma Patients Receiving Temozolomide [Phase 2]
Phase 2 trial comparing aprepitant (Emend) plus ondansetron versus ondansetron alone to prevent chemotherapy-induced nausea and vomiting in …
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: Carbon Ion Radiotherapy for Recurrent Gliomas [NA]
The clinical trial evaluating carbon ion radiotherapy for recurrent gliomas has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-27Clinical Trial Update: [18F] FACBC and [18F] FLT PET Imaging in Central Nervous System Tumors [NA]
Clinical trial update reporting completed results for PET imaging using [18F] FACBC and [18F] FLT in patients with brain cancer and gliomas.
-
CLINICAL_TRIALS trial_result · 2018-04-09Clinical Trial Update: MRS and 11C-methionine PET/CT in the Diagnosis of Glioma [NA]
A completed clinical trial evaluating magnetic resonance spectroscopy and 11C-methionine PET/CT for diagnosing glioma.
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: Interdisciplinary Rehabilitation of Patients With Glioma During Anti-cancer Treatment [NA]
A completed clinical trial assessing interdisciplinary rehabilitation for glioma patients during anti-cancer treatment.
-
CLINICAL_TRIALS trial_result · 2018-03-07Clinical Trial Update: Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma [Phase 2]
Phase 2 trial in glioblastoma comparing dose-dense temozolomide after chemoradiation to temozolomide with all-trans retinoic acid; results p…
-
CLINICAL_TRIALS trial_result · 2018-01-26Clinical Trial Update: Technical Performance Assessment of Tc-99m Tetrofosmin for Differentiation of Recurrence vs Radiation Necrosis in Patients With Glioma [Phase 2]
Phase 2 trial update evaluating Tc-99m tetrofosmin for differentiating glioma recurrence from radiation necrosis.
-
CLINICAL_TRIALS trial_result · 2018-01-04Clinical Trial Update: A Study of Apatinib in Recurrent or Recurrent High-grade Glioma [Phase 2]
Phase 2 trial investigating apatinib in patients with recurrent high-grade glioma.
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96 [Phase 1]
A Phase 1 trial evaluating an autologous heat shock protein gp96 vaccine for glioblastoma/glioma has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Temozolomide and Radiation Therapy in Treating Patients With Gliomas [Phase 2]
A Phase 2 clinical trial evaluating the combination of temozolomide and radiation therapy for gliomas has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2017-09-20Clinical Trial Update: Weekly Vinblastine for Chemotherapy Naive Children With Progressive Low Grade Glioma (PLGGs) [Phase 2]
A Phase 2 clinical trial update evaluating weekly vinblastine in chemotherapy-naive children with progressive low-grade glioma.